Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Upper urinary tract pacemaker cells join the GLI club
Doris Herzlinger
Doris Herzlinger
Published February 21, 2011
Citation Information: J Clin Invest. 2011;121(3):836-838. https://doi.org/10.1172/JCI46400.
View: Text | PDF
Commentary

Upper urinary tract pacemaker cells join the GLI club

  • Text
  • PDF
Abstract

Mutations in GLI3, a component of the Sonic Hedgehog (Shh) signaling pathway, cause a variety of human developmental syndromes. In this issue of the JCI, Cain and colleagues show that tightly regulated GLI3 repressor activity is essential for Shh-dependent differentiation of upper urinary tract pacemaker cells and the efficient flow of urine from the kidney to the bladder. These results link defective pacemaker cell differentiation with hydronephrosis and provide a cellular basis for one of the abnormal renal defects observed in humans with the GLI3-linked disease Pallister-Hall syndrome.

Authors

Doris Herzlinger

×

Figure 1

The kidney outflow tract includes the renal calyces, pelvis, and ureter and is highly prone to congenital defects.

Options: View larger image (or click on image) Download as PowerPoint
The kidney outflow tract includes the renal calyces, pelvis, and ureter ...
Abnormalities that severely impair the flow of urine through the outflow tract lead to hydronephrosis and often permanent kidney damage. Known causes of hydronephrosis include outflow tract compression by ectopic renal vessels, structural occlusions intrinsic to the outflow tract, and aberrant outflow tract smooth muscle differentiation that results in aperistaltic ureter segments. The report by Cain et al. (13) shows that hydronephrosis can also be caused by inefficient, dysplastic peristalsis caused by an absence of upper urinary tract pacemakers, the specialized cells that trigger smooth muscle contractions.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts